drugset / Trial / NCT04044898
Pharmacokinetics and Safety of ALA in Acne Vulgaris
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the pharmacokinetics and safety of ALA in patients with moderate and severe acne vulgaris after single dose in different dosages.
Timeline
- Start
- 2021-01-12
- Primary completion
- 2021-07-30
- Completion
- 2021-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | 5 % | Topical |
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | 10 % | Topical |